State data reveal 2026 ACA marketplace enrollment losses are accelerating post open enrollment, as cancellations surge and ...

Alopecia areata affects ~2% globally and is associated with atopic/autoimmune overlap, psychological comorbidity, and a ...

New ADA 2026 data show diabetic ketoacidosis hospitalizations rising 24%, driven by poor ketone monitoring and symptom recognition gaps across all ages. A key driver of that burden is recognition—or ...

A 546-patient, multicountry phase 3 trial randomized participants on insulin glargine (± metformin/SGLT2 inhibitors) to ...

Kerry Rogers, MD, examines the underemphasized BTK inhibitor adverse effects that quietly erode patient quality of life—and ...

Influenza vaccine coverage increased 7.4% from 2017-2018 to 2019-2020, then fell 12.9% from 2019-2020 to 2022-2023 in this ...

Anne Komé, PharmD, CPP, BCACP, CDCES, a clinical pharmacist practitioner in the Endocrinology Clinic at the UNC Chapel Hill ...

Boehringer Ingelheim’s survodutide phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing ...

Inhaled insulin (Afrezza; MannKind Corporation) continues to build a case for broader adoption in pediatric diabetes care.

Metabolic comorbidities are mechanistically intertwined with psoriasis and PsA, with obesity reducing biologic responsiveness and insulin resistance potentially sustaining joint inflammation.

Diabetes disparities drive unequal CGM access and amputation risk, highlighting the need to address social, provider, and ...

The moisturizer, sunscreen, or shampoo used in daily routines may contain dozens of plastic-associated chemicals linked to ...